|
|
Article: Targeted Genetics Elects Nelson L. Levy, Ph.d., M.D. to Board of Directors; Fills Board Seat Previously Held by Martin P. Sutter.
- Article from:
- PR Newswire
- Article date:
- May 11, 1999
CopyrightCOPYRIGHT 1999 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SEATTLE, May 11 /PRNewswire/ -- Targeted Genetics Corporation (Nasdaq: TGEN) today announced that Nelson L. Levy, Ph.D., M.D., has been elected to its Board of Directors. Dr. Levy, 57, is currently Chairman and Chief Executive Officer of CoreTechs Corporation, a private consulting firm that focuses on the development of early stage technologies and provides consultation to the healthcare and biotechnology industries and the investment community serving them.
Previously, Dr. Levy served as President of Fujisawa Pharmaceutical Company, the North American subsidiary of Japan's third largest pharmaceutical company. Dr. Levy was responsible for all operations, ...